Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells (Q44225910)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells |
scientific article |
Statements
1 reference
Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells (English)
1 reference
Ramadevi Nimmanapalli
1 reference
Lianne Fuino
1 reference
Corinne Stobaugh
1 reference
Victoria Richon
1 reference
Kapil Bhalla
1 reference
21 November 2002
1 reference
1 reference
101
1 reference
8
1 reference
3236-3239
1 reference
Identifiers
1 reference
1 reference